Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

被引:6
|
作者
Gu, Lili [1 ]
Ju, Yue [1 ]
Hu, Min [1 ]
Zheng, Miao [1 ]
Li, Qin [1 ]
Zhang, Xinyue [1 ]
机构
[1] Hangzhou Med Coll, Key Lab Neuropsychiat Drug Res Zhejiang Prov, Hangzhou 310013, Peoples R China
关键词
PPAR gamma; Alzheimer's disease; Cholesterol; Inflammation; ACTIVATED-RECEPTOR-GAMMA; A-BETA CLEARANCE; NF-KAPPA-B; LIPID RAFTS; INTRACEREBRAL HEMORRHAGE; HEMATOMA RESOLUTION; THERAPEUTIC TARGET; AMYLOID-BETA; IN-VITRO; EXPRESSION;
D O I
10.1007/s11011-022-01139-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxidase proliferator receptors (PPARs) are defined as key sensors and regulators of cell metabolism, transcription factors activated by ligands, involved in lipid, glucose and amino acid metabolism, participating in the processes of cell differentiation, apoptosis, inflammation regulation, and acute and chronic nerve damage. Among them, PPAR gamma is expressed in different brain regions and can regulate lipid metabolism, mitochondrial disorders, oxidative stress, and cell apoptosis. It has anti-inflammatory activity and shows neuroprotection. The regulation of A beta levels in Alzheimer's disease involves cholesterol metabolism and inflammation, so this article first analyzes the biological functions of PPAR gamma, then mainly focuses on the relationship between cholesterol and inflammation and A beta, and elaborates on the regulation of PPAR gamma on key proteins and the corresponding molecules, which provides new ideas for the treatment of AD.
引用
收藏
页码:839 / 854
页数:16
相关论文
共 50 条
  • [1] Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease
    Lili Gu
    Yue Ju
    Min Hu
    Miao Zheng
    Qin Li
    Xinyue Zhang
    Metabolic Brain Disease, 2023, 38 : 839 - 854
  • [2] Research Progress on the Regulation of Resveratrol on Alzheimer’s Disease
    Wu L.
    Zhang H.
    Wu T.
    Chen N.
    Shipin Kexue/Food Science, 2023, 44 (03): : 237 - 245
  • [3] Research Progress of Epigenetic Modification in The Regulation of Alzheimer's Disease
    Lin Su-Yang
    Pan Zhao-Tao
    Ma Yu-Tao
    Gao Jun-Yan
    Shan Jiang-Hui
    Chu Chao-Yang
    Xie Kai
    Shen Wei
    Wang Qing-Juan
    Li Li-Ping
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2022, 49 (04) : 623 - 641
  • [4] Research Progress of Targeting Neuro-Immune Inflammation in the Treatment of Alzheimer's Disease
    Chen, Huize
    Deng, Chujun
    Meng, Zeyu
    Meng, Shengxi
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (11):
  • [5] Research Progress of Pyroptosis in Alzheimer's Disease
    Xue, Weiyue
    Cui, Di
    Qiu, Ye
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [6] Research Progress of Mitophagy in Alzheimer's Disease
    Yao, Jinglin
    Kan, Bohong
    Dong, Zhengjia
    Tang, Zhenyu
    CURRENT ALZHEIMER RESEARCH, 2023, 20 (12) : 827 - 844
  • [7] Research Progress on Alzheimer's Disease and Resveratrol
    Yan Yan
    Huihuang Yang
    Yuxun Xie
    Yuanlin Ding
    Danli Kong
    Haibing Yu
    Neurochemical Research, 2020, 45 : 989 - 1006
  • [8] Research Progress on Alzheimer's Disease and Resveratrol
    Yan, Yan
    Yang, Huihuang
    Xie, Yuxun
    Ding, Yuanlin
    Kong, Danli
    Yu, Haibing
    NEUROCHEMICAL RESEARCH, 2020, 45 (05) : 989 - 1006
  • [9] Research Progress in the Pathogenesis of Alzheimer’s Disease
    Chen Yi-Gang
    中华医学杂志英文版, 2018, 131 (13) : 1618 - 1624
  • [10] Research Progress in the Pathogenesis of Alzheimer's Disease
    Chen, Yi-Gang
    CHINESE MEDICAL JOURNAL, 2018, 131 (13) : 1618 - 1624